203 related articles for article (PubMed ID: 36640188)
41. Cytology adds value to monoclonal antibody Das-1 testing for detection of high-risk pancreatic cysts.
Heidarian A; Das KK; Mino-Kenudson M; Fernandez-Del Castillo C; Pitman MB
J Am Soc Cytopathol; 2021; 10(3):249-254. PubMed ID: 33541830
[TBL] [Abstract][Full Text] [Related]
42. Pancreatic ductal adenocarcinomas associated with intraductal papillary mucinous neoplasms (IPMNs) versus pseudo-IPMNs: relative frequency, clinicopathologic characteristics and differential diagnosis.
Muraki T; Jang KT; Reid MD; Pehlivanoglu B; Memis B; Basturk O; Mittal P; Kooby D; Maithel SK; Sarmiento JM; Christians K; Tsai S; Evans D; Adsay V
Mod Pathol; 2022 Jan; 35(1):96-105. PubMed ID: 34518632
[TBL] [Abstract][Full Text] [Related]
43. Nonmucinous Cystic Lesions of the Pancreas.
Esposito I; Haeberle L
Arch Pathol Lab Med; 2022 Mar; 146(3):312-321. PubMed ID: 33503226
[TBL] [Abstract][Full Text] [Related]
44. Prevalence, Diagnosis and Management of Pancreatic Cystic Neoplasms: Current Status and Future Directions.
Farrell JJ
Gut Liver; 2015 Sep; 9(5):571-89. PubMed ID: 26343068
[TBL] [Abstract][Full Text] [Related]
45. Cystic pancreatic neoplasms in a tertiary gastroenterologic referral center: Evaluation of the diagnostic accuracy of endoscopic ultrasound, progression rate and malignancy rate in a large unicentric cohort.
Schedel J; Kaess M; Schorr W; Brookman-Amissah D; Alqahtan S; Pech O
Z Gastroenterol; 2023 Jun; 61(6):655-664. PubMed ID: 35878606
[TBL] [Abstract][Full Text] [Related]
46. A large multicenter study of recurrence after surgical resection of branch-duct intraductal papillary mucinous neoplasm of the pancreas.
Yan L; Siddiqui AA; Laique SN; Saumoy M; Kahaleh M; Yoo J; Kalra A; Mathew A; Sterling J; Rao R; Lieberman M; Cosgrove N; Sharaiha RZ
Minerva Gastroenterol Dietol; 2017 Mar; 63(1):50-54. PubMed ID: 27824244
[TBL] [Abstract][Full Text] [Related]
47. Impact of next-generation sequencing on the clinical diagnosis of pancreatic cysts.
Jones M; Zheng Z; Wang J; Dudley J; Albanese E; Kadayifci A; Dias-Santagata D; Le L; Brugge WR; Fernandez-del Castillo C; Mino-Kenudson M; Iafrate AJ; Pitman MB
Gastrointest Endosc; 2016 Jan; 83(1):140-8. PubMed ID: 26253016
[TBL] [Abstract][Full Text] [Related]
48. [Differential diagnosis and radiological management of cystic pancreatic lesions].
Buerke B; Heindel W; Wessling J
Rofo; 2010 Oct; 182(10):852-60. PubMed ID: 20563956
[TBL] [Abstract][Full Text] [Related]
49. Safety of endoscopic ultrasound-guided ethanol ablation for pancreatic cystic lesions: A single-center experience of 214 patients.
Choi JH; Lee SH; Choi YH; You MS; Shin BS; Paik WH; Ryu JK; Kim YT
Hepatobiliary Pancreat Dis Int; 2019 Dec; 18(6):562-568. PubMed ID: 31551143
[TBL] [Abstract][Full Text] [Related]
50. Management of Undifferentiated Solitary Mucinous Cystic Lesion of the Pancreas: A Clinical Dilemma.
Roch AM; Bigelow K; Schmidt CM; Carr RA; Jester AL; Ceppa EP; House MG; Zyromski NJ; Nakeeb A; Schmidt CM
J Am Coll Surg; 2017 Apr; 224(4):717-723. PubMed ID: 28126546
[TBL] [Abstract][Full Text] [Related]
51. Static and Dynamic
Lang M; Spektor AM; Hielscher T; Hoppner J; Glatting FM; Bicu F; Hackert T; Heger U; Pausch T; Gutjahr E; Rathke H; Giesel FL; Kratochwil C; Tjaden C; Haberkorn U; Röhrich M
J Nucl Med; 2023 Feb; 64(2):244-251. PubMed ID: 35906094
[TBL] [Abstract][Full Text] [Related]
52. Intraductal papillary mucinous neoplasms and other pancreatic cystic lesions.
Freeman HJ
World J Gastroenterol; 2008 May; 14(19):2977-9. PubMed ID: 18494045
[TBL] [Abstract][Full Text] [Related]
53. The Landmark Series: Intraductal Papillary Mucinous Neoplasms of the Pancreas-From Prevalence to Early Cancer Detection.
Pollini T; Wong P; Maker AV
Ann Surg Oncol; 2023 Mar; 30(3):1453-1462. PubMed ID: 36600097
[TBL] [Abstract][Full Text] [Related]
54. CT attenuation of unilocular pancreatic cystic lesions to differentiate pseudocysts from mucin-containing cysts.
Chalian H; Töre HG; Miller FH; Yaghmai V
JOP; 2011 Jul; 12(4):384-8. PubMed ID: 21737901
[TBL] [Abstract][Full Text] [Related]
55. Integration of KRAS testing in the diagnosis of pancreatic cystic lesions: a clinical experience of 618 pancreatic cysts.
Nikiforova MN; Khalid A; Fasanella KE; McGrath KM; Brand RE; Chennat JS; Slivka A; Zeh HJ; Zureikat AH; Krasinskas AM; Ohori NP; Schoedel KE; Navina S; Mantha GS; Pai RK; Singhi AD
Mod Pathol; 2013 Nov; 26(11):1478-87. PubMed ID: 23743931
[TBL] [Abstract][Full Text] [Related]
56. Integrating Molecular Analysis into the Pathologic Evaluation of Pancreatic Cysts.
Bell PD; Singhi AD
Surg Pathol Clin; 2022 Sep; 15(3):455-468. PubMed ID: 36049828
[TBL] [Abstract][Full Text] [Related]
57. Cystic lesions of the pancreas-is radical surgery really warranted?
Honselmann KC; Krauss T; Geserick S; Wellner UF; Wittel U; Hopt UT; Keck T; Bausch D
Langenbecks Arch Surg; 2016 Jun; 401(4):449-56. PubMed ID: 27048403
[TBL] [Abstract][Full Text] [Related]
58. The faith of non-surveilled pancreatic cysts: a bicentric retrospective study.
Surci N; Marchegiani G; Andrianello S; Pollini T; Mühlbacher J; Jomrich G; Richwien P; Tamandl D; Schindl M; Bassi C; Salvia R; Sahora K
Eur J Surg Oncol; 2022 Jan; 48(1):89-94. PubMed ID: 34148825
[TBL] [Abstract][Full Text] [Related]
59. Management of suspected pancreatic cystic neoplasms based on cyst size.
Walsh RM; Vogt DP; Henderson JM; Hirose K; Mason T; Bencsath K; Hammel J; Brown N
Surgery; 2008 Oct; 144(4):677-84; discussion 684-5. PubMed ID: 18847654
[TBL] [Abstract][Full Text] [Related]
60. Progression of Pancreatic Branch Duct Intraductal Papillary Mucinous Neoplasm Associates With Cyst Size.
Han Y; Lee H; Kang JS; Kim JR; Kim HS; Lee JM; Lee KB; Kwon W; Kim SW; Jang JY
Gastroenterology; 2018 Feb; 154(3):576-584. PubMed ID: 29074452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
